MSL
LGND icon

Mackay Shields LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Mackay Shields LLC’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,300
Closed -$1.36M – 1039
2021
Q1 		$1.36M Sell
14,300
-9,751
-41% -$922K 0.01% 912
2020
Q4 		$1.49M Buy
24,051
+320
+1% +$18.2K 0.01% 961
2020
Q3 		$1.41M Buy
23,731
+2,565
+12% +$175K 0.01% 913
2020
Q2 		$1.48M Sell
21,166
-3,847
-15% -$244K 0.01% 894
2020
Q1 		$1.14M Buy
25,013
+3,206
+15% +$182K 0.01% 908
2019
Q4 		$1.42M Sell
21,807
-3,046
-12% -$204K 0.01% 986
2019
Q3 		$1.54M Sell
24,853
-962
-4% -$60.4K 0.01% 1008
2019
Q2 		$1.84M Buy
25,815
+15,202
+143% +$1.12M 0.01% 929
2019
Q1 		$832K Sell
10,613
-321
-3% -$24.3K 0.01% 1055
2018
Q4 		$926K Sell
10,934
-468
-4% -$49.9K 0.01% 964
2018
Q3 		$1.95M Sell
11,402
-160
-1% -$24.1K 0.01% 712
2018
Q2 		$1.5M Sell
11,562
-3,367
-23% -$376K 0.01% 852
2018
Q1 		$1.54M Buy
+14,929
New +$1.48M 0.01% 866

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mackay Shields LLC's LGND Position: Q2 2021 in Review

Mackay Shields LLC sold out of Ligand Pharmaceuticals (LGND) in Q2 2021, closing a stake of 14,300 shares — an estimated $1.36M sold.

Mackay Shields LLC first reported a position in LGND in Q1 2018 and held it in 13 quarters. The position peaked at $1.95M in Q3 2018. 212 funds tracked by Wall St. Rank hold LGND as of Q2 2021.

  • Mackay Shields LLC reported no remaining Ligand Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 14,300 Ligand Pharmaceuticals shares in Q2 2021, an estimated $1.36M.
  • Mackay Shields LLC first reported a position in Ligand Pharmaceuticals in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's Ligand Pharmaceuticals position peaked at $1.95M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.